Clara Nan-Hi Lee1,2,3, Michael Patrick Pignone4,5, Allison M Deal6, Lillian Blizard7, Caprice Hunt8, Ruth Huh6, Yuen-Jong Liu9, Peter Anthony Ubel5,10,11. 1. Department of Plastic Surgery, College of Medicine, The Ohio State University, Columbus. 2. The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus. 3. Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus. 4. Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin. 5. Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina. 6. Lineberger Comprehensive Cancer Center Biostatistics Core Facility, University of North Carolina, Chapel Hill. 7. Gastrointestinal Unit, Massachusetts General Hospital, Boston. 8. Department of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill. 9. Department of Surgery, University of North Carolina Hospitals, University of North Carolina, Chapel Hill. 10. School of Business, Duke University, Durham, North Carolina. 11. School of Public Policy and Medicine, Duke University, Durham, North Carolina.
Abstract
Importance: Making a good decision about breast reconstruction requires predicting how one would feel after the procedure, but people tend to overestimate the impact of events on future well-being. Objective: To assess how well patients predict future well-being after mastectomy, with or without immediate reconstruction, with the following a priori hypotheses: Patients will overestimate the negative impact of mastectomy and positive impact of reconstruction, and prediction accuracy will be associated with decision satisfaction and decision regret. Design, Setting, and Participants: This prospective cohort survey study was conducted at a single, multidisciplinary academic oncology clinic from July 2012 to February 2014. Adult women undergoing mastectomy for stage 1, 2, or 3 invasive ductal or lobular breast cancer, ductal carcinoma in situ, or prophylaxis were invited to participate. Data analysis was conducted from September 2015 to October 2017. Exposures: Mastectomy only or mastectomy with immediate reconstruction. Main Outcomes and Measures: Preoperative measures predicted were 12-month happiness (Cantril Ladder) and quality of life, predicted satisfaction with breasts, sexual attractiveness, breast numbness, and pain (measured with BreastQ single items). Measures at 12 months postoperative added the Decision Regret Scale and Satisfaction With Decisions Scale. Results: Of 214 eligible patients, 182 consecutive patients were approached, and 145 enrolled (80%). Of these 145 patients, 131 returned surveys (72%) and 111 of these remained at 12 months (88%). Fifteen who had delayed reconstruction were excluded from analysis, leaving a final cohort of 96 women; 54 had not had reconstruction and 42 had had reconstruction. The mean (SD) age of the cohort was 53.9 (12.1) years; 73 (76%) were white; 50 (52%) were college graduates; 54 (56%) were privately insured; 69 (72%) had disease at stages 0, 1, or 2; and 31 (32%) received adjuvant radiation. Patients having mastectomy without reconstruction underestimated future well-being in all domains. Differences were significant for quality of life scores (mean predicted, 68 vs mean actual, 74; t50, -2.47; P = .02) and satisfaction with breasts-clothed (mean predicted, 2.4 vs mean actual, 2.8; t49, -2.11; P = .04). Patients undergoing mastectomy with reconstruction overestimated future well-being in all but 1 domain. Differences were significant for satisfaction with breasts-unclothed (mean predicted, 3.1 vs mean actual, 2.6; t41, 2.70; P = .01); sexual attractiveness-clothed (mean predicted, 3.7 vs mean actual, 3.3; t39, 2.29; P = .03); sexual attractiveness-unclothed (mean predicted, 3.3 vs mean actual, 2.3; t40, 5.57; P < .001). Both groups experienced more numbness than predicted (mean predicted, 2.79 and 2.72 for mastectomy only and mastectomy with reconstruction groups, respectively; mean actual, 3.52 and 3.56, respectively; t47, -3.4 and t38, -2.9, respectively; P < .01). Patients who were less happy (β = 6.3; P = .02) or had greater pain (β = 8.7; P < .001) than predicted had greater regret. Conclusions and Relevance: Patients underestimated future well-being after mastectomy and overestimated well-being after reconstruction. Misprediction was associated with regret. Decision support for breast reconstruction should address expectations about well-being.
Importance: Making a good decision about breast reconstruction requires predicting how one would feel after the procedure, but people tend to overestimate the impact of events on future well-being. Objective: To assess how well patients predict future well-being after mastectomy, with or without immediate reconstruction, with the following a priori hypotheses: Patients will overestimate the negative impact of mastectomy and positive impact of reconstruction, and prediction accuracy will be associated with decision satisfaction and decision regret. Design, Setting, and Participants: This prospective cohort survey study was conducted at a single, multidisciplinary academic oncology clinic from July 2012 to February 2014. Adult women undergoing mastectomy for stage 1, 2, or 3 invasive ductal or lobular breast cancer, ductal carcinoma in situ, or prophylaxis were invited to participate. Data analysis was conducted from September 2015 to October 2017. Exposures: Mastectomy only or mastectomy with immediate reconstruction. Main Outcomes and Measures: Preoperative measures predicted were 12-month happiness (Cantril Ladder) and quality of life, predicted satisfaction with breasts, sexual attractiveness, breast numbness, and pain (measured with BreastQ single items). Measures at 12 months postoperative added the Decision Regret Scale and Satisfaction With Decisions Scale. Results: Of 214 eligible patients, 182 consecutive patients were approached, and 145 enrolled (80%). Of these 145 patients, 131 returned surveys (72%) and 111 of these remained at 12 months (88%). Fifteen who had delayed reconstruction were excluded from analysis, leaving a final cohort of 96 women; 54 had not had reconstruction and 42 had had reconstruction. The mean (SD) age of the cohort was 53.9 (12.1) years; 73 (76%) were white; 50 (52%) were college graduates; 54 (56%) were privately insured; 69 (72%) had disease at stages 0, 1, or 2; and 31 (32%) received adjuvant radiation. Patients having mastectomy without reconstruction underestimated future well-being in all domains. Differences were significant for quality of life scores (mean predicted, 68 vs mean actual, 74; t50, -2.47; P = .02) and satisfaction with breasts-clothed (mean predicted, 2.4 vs mean actual, 2.8; t49, -2.11; P = .04). Patients undergoing mastectomy with reconstruction overestimated future well-being in all but 1 domain. Differences were significant for satisfaction with breasts-unclothed (mean predicted, 3.1 vs mean actual, 2.6; t41, 2.70; P = .01); sexual attractiveness-clothed (mean predicted, 3.7 vs mean actual, 3.3; t39, 2.29; P = .03); sexual attractiveness-unclothed (mean predicted, 3.3 vs mean actual, 2.3; t40, 5.57; P < .001). Both groups experienced more numbness than predicted (mean predicted, 2.79 and 2.72 for mastectomy only and mastectomy with reconstruction groups, respectively; mean actual, 3.52 and 3.56, respectively; t47, -3.4 and t38, -2.9, respectively; P < .01). Patients who were less happy (β = 6.3; P = .02) or had greater pain (β = 8.7; P < .001) than predicted had greater regret. Conclusions and Relevance: Patients underestimated future well-being after mastectomy and overestimated well-being after reconstruction. Misprediction was associated with regret. Decision support for breast reconstruction should address expectations about well-being.
Authors: Caprice K Christian; Joyce Niland; Stephen B Edge; Rebecca A Ottesen; Melissa E Hughes; Richard Theriault; John Wilson; Charles A Hergrueter; Jane C Weeks Journal: Ann Surg Date: 2006-02 Impact factor: 12.969
Authors: Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann Journal: J Clin Oncol Date: 2005-10-03 Impact factor: 44.544
Authors: M Holmes-Rovner; J Kroll; N Schmitt; D R Rovner; M L Breer; M L Rothert; G Padonu; G Talarczyk Journal: Med Decis Making Date: 1996 Jan-Mar Impact factor: 2.583
Authors: Andrea L Pusic; Anne F Klassen; Amie M Scott; Jennifer A Klok; Peter G Cordeiro; Stefan J Cano Journal: Plast Reconstr Surg Date: 2009-08 Impact factor: 4.730
Authors: Jamie C Brehaut; Annette M O'Connor; Timothy J Wood; Thomas F Hack; Laura Siminoff; Elisa Gordon; Deb Feldman-Stewart Journal: Med Decis Making Date: 2003 Jul-Aug Impact factor: 2.583
Authors: Karen R Sepucha; Aisha T Langford; Jeffrey K Belkora; Yuchiao Chang; Beverly Moy; Ann H Partridge; Clara N Lee Journal: Med Decis Making Date: 2019-07-29 Impact factor: 2.583
Authors: Jacqueline A Ter Stege; Leonie A E Woerdeman; Daniela E E Hahn; Martine A van Huizum; Frederieke H van Duijnhoven; Jacobien M Kieffer; Valesca P Retèl; Kerry A Sherman; Arjen J Witkamp; Hester S A Oldenburg; Eveline M A Bleiker Journal: BMC Med Inform Decis Mak Date: 2019-08-19 Impact factor: 2.796
Authors: Jacqueline A Ter Stege; Daniela B Raphael; Hester S A Oldenburg; Martine A van Huizum; Frederieke H van Duijnhoven; Daniela E E Hahn; Regina The; Klemens Karssen; Eveline M L Corten; Irene S Krabbe-Timmerman; Menno Huikeshoven; Quinten P Q Ruhé; Nikola A N Kimmings; Wies Maarse; Kerry A Sherman; Arjen J Witkamp; Leonie A E Woerdeman; Eveline M A Bleiker Journal: Health Expect Date: 2021-10-28 Impact factor: 3.377
Authors: Hansje P Smeele; Rachel C H Dijkstra; Merel L Kimman; René R W J van der Hulst; Stefania M H Tuinder Journal: Patient Date: 2022-01-18 Impact factor: 3.481